AP
MRNA icon

Advisor Partners’s Moderna MRNA Stock Holding History

Advisor Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$938K Buy
6,569
+2,240
+52% +$320K 0.07% 305
2022
Q1 		$746K Sell
4,329
-651
-13% -$110K 0.05% 390
2021
Q4 		$1.26M Buy
4,980
+73
+1% +$21.3K 0.08% 253
2021
Q3 		$1.89M Buy
+4,907
New +$1.81M 0.13% 160

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor Partners's MRNA Position: Q2 2022 in Review

Advisor Partners increased its Moderna (MRNA) stake by 52% in Q2 2022, buying an estimated $320K and bringing the position to 6,569 shares worth $938K. The position accounts for 0.07% of the portfolio, ranked #305.

Advisor Partners first reported a position in MRNA in Q3 2021 and has held it in 4 quarters since. The position peaked at $1.89M in Q3 2021. 982 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Advisor Partners held 6,569 shares of Moderna worth $938K as of Q2 2022.
  • Advisor Partners bought 2,240 Moderna shares in Q2 2022, an estimated $320K.
  • Moderna made up 0.07% of Advisor Partners's portfolio in Q2 2022, its #305 holding.
  • Advisor Partners first reported a position in Moderna in Q3 2021 and has held it in 4 quarters since.
  • Advisor Partners's Moderna position peaked at $1.89M in Q3 2021.
  • 982 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.